Epidemic outbreaks control involving Staphylococcus aureus with reduced sensitivity to glycopeptides;Contrôle de phénomènes épidémiques dus à des souches de Staphylococcus aureus de sensibilité diminuée aux glycopeptides

Pathologie Biologie

Volumn 51, Issue 8-9, 2003, Pages 469-473

  Mallaval, F O ^a   Carricajo, A ^b   Martin, I ^a   Fonsale, N ^b   Grattard, F ^c   Fascia, P ^a   Aubert, G ^b   Zeni, F ^b   Lucht, F ^a   Pozzetto, B ^c   Berthelot, P ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b SERVICE DE NEUROLOGIE   (France)

^c HÔPITAL NORD   (France)

Author keywords

HeteroGISA; Outbreak; S. aureus

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; MACROLIDE; METICILLIN; PRISTINAMYCIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIOLYSIS; CONFERENCE PAPER; EPIDEMIC; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS;

EID: 0142055876     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00148-2     Document Type: Conference Paper

References (15)

1. Mesures d'isolement. Dans 100 recommandations pour la surveillance et la prévention des infections nosocomiales. Ministère de l'emploi et de la solidarité; 1999. p. 59-62.
2. Tronel H, Huc B, Bertrand X, Thouverez M, Marchal A, Talon D. Aspects épidémiologiques de Staphylococcus aureus résistant à la méticilline dans un centre hospitalier de taille moyenne. Med Mal Infect 2002;32:212-22.
3. Reverdy ME, Jarraud S, Bobin-Dubreux S, Burel E, Girardo P, Lina G, et al. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001;7:267-72.
4. Carricajo A, Mallaval FO, Fonsale N, Vautrin AC, Aubert G. Recherche des souches de Staphyloccocus aureus de sensibilité diminué aux glycopeptides dans un hôpital universitaire (juin 1999-février 2000). Méd Mal Infect 2001;31:683-4.
5. Guerin F, Buu-Hoi A, Mainardi JL, Kac G, Colardelle N, Vaupre S, et al. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 2000;38:2985-8.
6. Pina P, Marlière C, Vandenesch F, Bedos JP, Etienne J, Allouch PY. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital. Clin Infect Dis 2000; 31:1306-8.
7. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vana resistance gene. N Engl J Med 2003 Apr 3;348(14):1342-7.
8. Fridkin SK. Vancomycin - intermediate and resistant Staphylococcus aureus: What the infectious disease specialist needs to know. Clin Infect Dis 2001;32:108-15.
9. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Horoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3.
10. Chesneau O, Morvan A, El Solh N. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J Antimicrob Chemother 2000;45:887-90.
11. Walsh TR, Howe RA, Wootton M, Bennett PM, MacGowan AP. Detection of glycopeptide resistance in Staphylococcus aureus. J Antimicrob Chemother 2001;47:357-8.
12. Howe RA, Wootton M, Walsh TR, Bennett PM, Macgowan AP. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother 2000;45:130-2.
13. Berthelot P, Grattard F, Fascia P, Fichtner C, Moulin M, Lavocat MP, et al. Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit. Infect Control Hosp Epidemiol 2003;24:299-300.
14. Blok HEM, Vriens MR, Weersink AJL, Troelstra A. Carriage of methicillin-resistant Staphylococcus aureus (MRSA) after discharge from hospital: follow-up for how long? J Hosp Infect 2001:325-7.
15. e Édition. Le POPI Guide de traitement référence pour une bonne pratique médical. Eds 2M2; 2001. p. 278-86.